Case Report

Metastatic Methicillin-Sensitive Staphylococcus aureus Infection

Authors: Helen Gharwan, MD, DrSci, Anand Dutta, MD

Abstract

Staphylococcus aureus bacteremia (SAB) is a common and increasingly recognized hospital- and community-acquired infection. To minimize morbidity and mortality, it is essential to determine which patients are at high risk for metastatic SAB. The risk-scoring system described by Fowler et al and the APACHE II scoring system can be helpful in identifying the clinical predictors of metastatic SAB. Herein we describe a case of metastatic methicillin-sensitive SAB in a previously healthy 19-year-old woman that was complicated by a disseminated pneumonia, an ischemic toe, and an acute intracranial hemorrhage. We also discuss the clinical factors associated with increased risk for complications from SAB and the currently available treatment options.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Blot SI, Vandewoude KH, Hoste EA, et al. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002;162:2229-2235.
 
2. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureusbacteremia. Arch Intern Med 2003;163:2066-2072.
 
3. del Rio A, Cervera C, Moreno A, et al. Patients at risk of complications of Staphylococcus aureusbloodstream infection. Clin Infect Dis 2009;48(suppl 4):S246-S253.
 
4. Lina G, Piémont Y, Godail-Gamot F, et al. Involvement of Panton-Valentin leukocidin-producingStaphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-1132.
 
5. Lopez-Aguilar C, Perez-Roth E, Moreno A, et al. Association between the presence of the Panton-Valentine leukocidin-encoding gene and a lower rate of survival among hospitalized pulmonary patients with staphylococcal disease. J Clin Microbiol 2007;45:274-276.
 
6. Shively BK, Gurule FT, Roldan CA, et al. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991;18:391-397.
 
7. Cribier G, Prévost G, Couppie P, et al. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infection? An epidemiological and experimental study. Dermatology 1992;185:175-185.
 
8. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentin leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002;359:753-759.
 
9. Corey GR. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis2009;48(suppl 4):S254-S259.
 
10. Rouzic N, Janvier F, Libert N, et al. Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes. J Clin Microbiol 2010;48:1952-1955.